Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield.

BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ ...

The startup is developing a medicine that can very specifically degrade cancerous forms of EGFR, the target of several ...

MGM Cancer Institute successfully treats a 41-year-old man with advanced tongue cancer through chemotherapy, surgery, and ...

Baystreet.ca News Commentary – The war on cancer is moving into a high-tech era of molecular-guided defense. The genomics in cancer care market is now projected to hit a staggering ...

First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s ...